Rheumatoid arthritis prevention with abatacept - long-term outcome study

Not Applicable

Completed

• Conditions: Rheumatoid arthritis; Musculoskeletal Diseases; Rheumatoid arthritis, unspecified

• Registration Number: ISRCTN12680338
• Lead Sponsor: Kings College London and Guy's and St Thomas' NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-09
• Study Completion: 2023-07-31
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 143

Inclusion Criteria

Current inclusion criteria as of 20/07/2021:
1. Male or female participants, aged =18 years.
2. All participants deemed eligible and randomised to the APIPPRA study.
3. All participants who completed at least one APIPPRA study visit.
4. All participants who are willing to give written informed consent and comply with the requirements of the ALTO study protocol.

Previous inclusion criteria:
1. Male or female participants, aged =18 years
2. All participants deemed eligible and randomised to the APIPPRA study
3. All participants who completed at least one APIPPRA study visit
4. All participants who are willing to consent to the ALTO study

Exclusion Criteria

1. Participants who are still participating in the APIPPRA study
2. Participants ineligible and randomised to the APIPPRA study in error
3. Participants deemed eligible and randomised to the APIPPRA study but who never received study drug
4. Those unable to give informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified